WallStSmart

Nu Skin Enterprises Inc (NUS)vsPepsiCo Inc (PEP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

PepsiCo Inc generates 6946% more annual revenue ($96.90B vs $1.38B). PEP leads profitability with a 10.8% profit margin vs -15.7%. NUS appears more attractively valued with a PEG of 0.78. PEP earns a higher WallStSmart Score of 69/100 (B-).

NUS

Hold

47

out of 100

Grade: D+

Growth: 2.0Profit: 4.5Value: 7.7Quality: 7.5
Piotroski: 5/9Altman Z: 4.45

PEP

Strong Buy

69

out of 100

Grade: B-

Growth: 6.7Profit: 8.0Value: 4.7Quality: 4.0
Piotroski: 3/9Altman Z: 2.26
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

NUSUndervalued (+53.3%)

Margin of Safety

+53.3%

Fair Value

$21.79

Current Price

$4.79

$17.00 discount

UndervaluedFair: $21.79Overvalued
PEPFair Value (-2.5%)

Margin of Safety

-2.5%

Fair Value

$140.01

Current Price

$142.19

$2.18 premium

UndervaluedFair: $140.01Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

NUS3 strengths · Avg: 9.3/10
Price/BookValuation
0.3x10/10

Reasonable price relative to book value

Altman Z-ScoreHealth
4.4510/10

Safe zone — low bankruptcy risk

PEG RatioValuation
0.788/10

Growing faster than its price suggests

PEP4 strengths · Avg: 9.3/10
Return on EquityProfitability
47.5%10/10

Every $100 of equity generates 47 in profit

EPS GrowthGrowth
137.0%10/10

Earnings expanding 137.0% YoY

Market CapQuality
$188.84B9/10

Large-cap with strong market position

Free Cash FlowQuality
$1.50B8/10

Generating 1.5B in free cash flow

Areas to Watch

NUS4 concerns · Avg: 2.5/10
Market CapQuality
$230.73M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
6.9%3/10

ROE of 6.9% — below average capital efficiency

Revenue GrowthGrowth
-17.1%2/10

Revenue declined 17.1%

EPS GrowthGrowth
-98.2%2/10

Earnings declined 98.2%

PEP4 concerns · Avg: 3.0/10
PEG RatioValuation
1.534/10

Expensive relative to growth rate

Price/BookValuation
8.8x4/10

Trading at 8.8x book value

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Debt/EquityHealth
2.411/10

Elevated debt levels

Comparative Analysis Report

WallStSmart Research

Bull Case : NUS

The strongest argument for NUS centers on Price/Book, Altman Z-Score, PEG Ratio. PEG of 0.78 suggests the stock is reasonably priced for its growth.

Bull Case : PEP

The strongest argument for PEP centers on Return on Equity, EPS Growth, Market Cap.

Bear Case : NUS

The primary concerns for NUS are Market Cap, Return on Equity, Revenue Growth.

Bear Case : PEP

The primary concerns for PEP are PEG Ratio, Price/Book, Piotroski F-Score. Debt-to-equity of 2.41 is elevated, increasing financial risk.

Key Dynamics to Monitor

NUS profiles as a turnaround stock while PEP is a value play — different risk/reward profiles.

NUS carries more volatility with a beta of 0.97 — expect wider price swings.

PEP is growing revenue faster at 6.4% — sustainability is the question.

PEP generates stronger free cash flow (1.5B), providing more financial flexibility.

Bottom Line

PEP scores higher overall (69/100 vs 47/100). NUS offers better value entry with a 53.3% margin of safety. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Nu Skin Enterprises Inc

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA

Nu Skin Enterprises, Inc. develops and distributes wellness and personal care products globally. The company is headquartered in Provo, Utah.

Visit Website →

PepsiCo Inc

CONSUMER DEFENSIVE · BEVERAGES - NON-ALCOHOLIC · USA

PepsiCo, Inc. is an American based multinational food, snack, and beverage corporation headquartered in Harrison, New York, in the hamlet of Purchase. PepsiCo's business encompasses all aspects of the food and beverage market. It oversees the manufacturing, distribution, and marketing of its products.

Want to dig deeper into these stocks?